Loading company…
Moirai Biodesign is a Barcelona biotech firm making RNA diagnostics technology and AI-based RNA design software.
Founded in 2016 in Barcelona, Spain, Moirai Biodesign SL develops RNA diagnostics technology that detects RNA from point-of-care settings to high-throughput labs. It also builds AI-driven RNA design software for small and long mRNA molecules, sold to laboratories and pharmaceutical companies. The company raised seed funding from RebelBio and SOSV on December 18, 2019, and reported 2023 revenue of USD 38,641.50 with EBITDA of USD 4,222.60. It is at Seed stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in